Retractable Technologies (NYSE:RVP) Coverage Initiated at StockNews.com

StockNews.com started coverage on shares of Retractable Technologies (NYSE:RVPFree Report) in a research note released on Thursday morning. The brokerage issued a hold rating on the stock.

Retractable Technologies Price Performance

Shares of RVP stock opened at $0.62 on Thursday. The company has a debt-to-equity ratio of 0.01, a current ratio of 8.57 and a quick ratio of 5.92. The firm’s 50-day moving average is $0.70 and its two-hundred day moving average is $0.91. Retractable Technologies has a 12 month low of $0.56 and a 12 month high of $1.34. The company has a market capitalization of $18.56 million, a PE ratio of -1.15 and a beta of 1.98.

Insider Activity

In related news, CEO Thomas J. Shaw bought 71,422 shares of the stock in a transaction on Friday, September 20th. The stock was bought at an average price of $0.82 per share, with a total value of $58,566.04. Following the completion of the purchase, the chief executive officer now directly owns 14,743,907 shares in the company, valued at $12,090,003.74. This represents a 0.49 % increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. In the last 90 days, insiders have bought 179,279 shares of company stock valued at $136,839. 55.00% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On Retractable Technologies

A hedge fund recently bought a new stake in Retractable Technologies stock. PFG Investments LLC bought a new stake in Retractable Technologies, Inc. (NYSE:RVPFree Report) in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm bought 34,600 shares of the company’s stock, valued at approximately $27,000. PFG Investments LLC owned about 0.12% of Retractable Technologies as of its most recent filing with the Securities and Exchange Commission. Institutional investors and hedge funds own 7.58% of the company’s stock.

About Retractable Technologies

(Get Free Report)

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.

Recommended Stories

Receive News & Ratings for Retractable Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Retractable Technologies and related companies with MarketBeat.com's FREE daily email newsletter.